Related Experiment Video
Updated: Mar 19, 2026

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
Published on: March 28, 2025
Risk Factors for Thrombosis, Overshunting and Death in Infants after Modified Blalock-Taussig Shunt
Mehmet Küçük1, Rahmi Özdemir1, Mustafa Karaçelik2
1Department of Pediatric Cardiology;
Insights
A Modified Blalock-Taussig shunt (MBTS) may improve lung blood flow in infants with congenital heart defects. A low preoperative partial thromboplastin time (aPTT) may indicate a higher risk of thrombosis after MBTS surgery.
Area of Science:
- Pediatric Cardiology
- Congenital Heart Surgery
- Neonatal Intensive Care
Background:
- The Modified Blalock-Taussig shunt (MBTS) procedure is crucial for managing certain congenital heart defects in infants.
- This study focuses on risk factors for thrombosis, overshunting, and mortality following MBTS in young children.
Purpose of the Study:
- To evaluate risk factors associated with the Modified Blalock-Taussig shunt (MBTS) procedure.
- To identify predictors of thrombosis, overshunting, and death in infants undergoing MBTS.
Main Methods:
- Retrospective analysis of 44 infants under 2 years who underwent MBTS between 2009-2013.
- Assessment of preoperative characteristics including hemoglobin, hematocrit, and coagulation parameters (PTT).
- Investigation of post-operative outcomes such as thrombosis, overcirculation, and mortality.
Main Results:
- 8 out of 44 patients died post-surgery; 4 patients (9.1%) experienced shunt thrombosis.
- Lower partial thromboplastin time (aPTT) was significantly associated with thrombosis (28.7s vs 35s, p=0.04).
- Overshunting occurred in 5 patients, with a higher shunt size/body weight ratio (1.25 vs 1.06).
Conclusions:
- Assessing risk factors for the MBTS operation is vital for patient outcomes.
- Preoperative low aPTT may serve as a predictive indicator for thrombosis in infants following MBTS surgery.
- Further research is warranted to refine risk stratification and improve surgical outcomes.
Background:
The Modified Blalock-Taussig shunt procedure can provide increased flow of blood to the lungs for babies born with certain congenital heart defects. We evaluated 44 subjects under 2 years of age who had a Modified Blalock-Taussig shunt (MBTS) procedure performed from 2009-2013, to investigate risk factors for thrombosis, overshunting and death.
Methods:
The study subjects included in our investigation were severely cyanotic newborns with pulmonary stenosis or atresia and duct dependent circulation, and infants having Tetralogy of Fallot with small pulmonary arteries who underwent a MBTS procedure in our facility from 2009-2013. We duly noted patient preoperative characteristics such as hemoglobin, hematocrit, mean platelet volume, prothrombin time and partial thromboplastin time. Our study investigated the risk factors for post-operative overcirculation, thrombosis and death.
Results:
The age and weight of patients in our study at the time of procedure ranged from 1 day to 20 months old (median 12 days), and 2.4 kg to 12 kg (mean 4.6 kg), respectively. A total of 8 patients died following surgery, and. 4 (9.1%) had shunt thrombosis, of which one died during shunt revision. Partial thromboplastin time was 28.7 seconds in patients with thrombosis, and 35 in all other patients (p = 0.04). Overcirculation was detected in 5 patients; shunt size/body weight was 1.25 in patients who had overcirculation, and 1.06 in all other patients.
Conclusions:
It is important to assess risk factors associated with the MBTS operation. The results of our study suggest that a preoperative low aPTT value may be an indicator for thrombosis in infants who have undergone MBTS surgery.
More Related Videos
09:00The Rabbit Blood-shunt Model for the Study of Acute and Late Sequelae of Subarachnoid Hemorrhage: Technical Aspects
Published on: October 2, 2014
14:59Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
Published on: October 14, 2022
Related Concept Videos
Venous Thrombosis I: Introduction
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care